关注
prof. dr hab. Karolina Pytka
prof. dr hab. Karolina Pytka
Jagiellonian University Medical College
在 uj.edu.pl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Essential elements in depression and anxiety. Part I
K Młyniec, CL Davies, IG de Agüero Sánchez, K Pytka, B Budziszewska, ...
Pharmacological reports 66 (4), 534-544, 2014
2632014
Serotonin receptors in depression and anxiety: Insights from animal studies
E Żmudzka, K Sałaciak, J Sapa, K Pytka
Life sciences 210, 106-124, 2018
1812018
The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect
K Pytka, K Podkowa, A Rapacz, A Podkowa, E Żmudzka, A Olczyk, J Sapa, ...
Pharmacological Reports 68 (2), 263-274, 2016
1022016
The role of glutamatergic, GABA-ergic, and cholinergic receptors in depression and antidepressant-like effect
K Pytka, A Dziubina, K Młyniec, A Dziedziczak, E Żmudzka, A Furgała, ...
Pharmacological Reports 68 (2), 443-450, 2016
722016
Synthesis and evaluation of antidepressant‐like activity of some 4‐substituted 1‐(2‐methoxyphenyl) piperazine derivatives
AM Waszkielewicz, K Pytka, A Rapacz, E Wełna, M Jarzyna, G Satała, ...
Chemical Biology & Drug Design 85 (3), 326-335, 2015
582015
Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models
K Pytka, A Partyka, M Jastrzębska-Więsek, A Siwek, M Głuch-Lutwin, ...
PLoS One 10 (11), e0142499, 2015
502015
Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety
AM Waszkielewicz, A Gunia, N Szkaradek, K Pytka, A Siwek, G Satała, ...
Bioorganic & medicinal chemistry letters 23 (15), 4419-4423, 2013
452013
Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone
N Szkaradek, A Rapacz, K Pytka, B Filipek, A Siwek, M Cegła, H Marona
Bioorganic & medicinal chemistry 21 (2), 514-522, 2013
452013
Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system
K Pytka, A Rapacz, M Zygmunt, A Olczyk, A Waszkielewicz, J Sapa, ...
Pharmacological Reports 67 (1), 160-165, 2015
412015
A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity
M Dudek, J Knutelska, M Bednarski, L Nowiński, M Zygmunt, B Mordyl, ...
Plos one 10 (10), e0141327, 2015
392015
Single Administration of HBK-15—a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist—Reverses Depressive-Like Behaviors in Mouse Model of Depression …
K Pytka, M Głuch-Lutwin, M Kotańska, A Waszkielewicz, A Kij, M Walczak
Molecular Neurobiology 55, 3931-3945, 2018
382018
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
K Sałaciak, K Pytka
Neuroscience & Biobehavioral Reviews 132, 1114-1136, 2022
372022
The calcium/calmodulin-dependent kinases II and IV as therapeutic targets in neurodegenerative and neuropsychiatric disorders
K Sałaciak, A Koszałka, E Żmudzka, K Pytka
International Journal of Molecular Sciences 22 (9), 4307, 2021
332021
Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity
A Bucki, M Marcinkowska, J Sniecikowska, K Wieckowski, M Pawłowski, ...
Journal of Medicinal Chemistry 60 (17), 7483-7501, 2017
312017
The antidepressant-and anxiolytic-like activities of new xanthone derivative with piperazine moiety in behavioral tests in mice
K Pytka, E Żmudzka, K Lustyk, A Rapacz, A Olczyk, A Gałuszka, ...
Indian journal of pharmacology 48 (3), 286-291, 2016
302016
Novel aryloxyethyl derivatives of 1-(1-benzoylpiperidin-4-yl) methanamine as the extracellular regulated kinases 1/2 (ERK1/2) phosphorylation-preferring serotonin 5-HT1A …
J Sniecikowska, M Gluch-Lutwin, A Bucki, A Wieckowska, A Siwek, ...
Journal of Medicinal Chemistry 62 (5), 2750-2771, 2019
292019
H3 histamine receptor antagonist pitolisant reverses some subchronic disturbances induced by olanzapine in mice
M Dudek, K Kuder, M Kołaczkowski, A Olczyk, E Żmudzka, A Rak, ...
Metabolic Brain Disease 31, 1023-1029, 2016
282016
The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl) piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT1A and 5-HT2A/C receptors activation
K Pytka, M Walczak, A Kij, A Rapacz, A Siwek, G Kazek, A Olczyk, ...
European Journal of Pharmacology 764, 537-546, 2015
282015
Biased agonism in drug discovery: Is there a future for biased 5-HT1A receptor agonists in the treatment of neuropsychiatric diseases?
K Sałaciak, K Pytka
Pharmacology & Therapeutics 227, 107872, 2021
242021
HBK-15 protects mice from stress-induced behavioral disturbances and changes in corticosterone, BDNF, and NGF levels
K Pytka, M Głuch-Lutwin, M Kotańska, E Żmudzka, M Jakubczyk, ...
Behavioural Brain Research 333, 54-66, 2017
242017
系统目前无法执行此操作,请稍后再试。
文章 1–20